Asunto(s)
Endometriosis/complicaciones , Enfermedades de los Genitales Femeninos/complicaciones , Neoplasias Uterinas/complicaciones , Adulto , Endometriosis/diagnóstico , Femenino , Enfermedades de los Genitales Femeninos/diagnóstico , Neoplasias de los Genitales Femeninos/diagnóstico , Humanos , Persona de Mediana Edad , Neoplasias Primarias Múltiples/diagnóstico , Neoplasias Uterinas/diagnósticoAsunto(s)
Endometriosis , Leiomioma , Neoplasias Primarias Múltiples , Neoplasias Uterinas , Adulto , Anciano , Femenino , Humanos , Persona de Mediana EdadAsunto(s)
Neoplasias Ováricas/diagnóstico , Adulto , Anciano , Femenino , Humanos , Persona de Mediana Edad , Neoplasias Ováricas/terapiaAsunto(s)
Preeclampsia/sangre , Bilirrubina/sangre , Glucemia/análisis , Proteínas Sanguíneas/análisis , Femenino , Humanos , Recién Nacido , EmbarazoRESUMEN
A patient with SLE in pregnancy is described. The disease first appeared at the end of the 25th week of pregnancy. Spontaneous delivery took place during the 37th gestation week. The baby weighed 2300 g, the Apgar score was 8/9. The parturient's condition deteriorated after delivery, the disease developed progressively and ended lethally after 5 months. The cause of death was a malignant form of SLE dominated by kidney and heat lesions. After being treated for anemia in the early neonatal period, the newborn continued developing satisfactorally. The relation between SLE and pregnancy and the differential diagnosis of SLE in pregnancy are discussed.
Asunto(s)
Lupus Eritematoso Sistémico/diagnóstico , Complicaciones del Embarazo/diagnóstico , Adulto , Femenino , Humanos , Recién Nacido , EmbarazoAsunto(s)
Acidosis/prevención & control , Etanolaminas/uso terapéutico , Fenoterol/uso terapéutico , Enfermedades Fetales/prevención & control , Complicaciones del Trabajo de Parto/tratamiento farmacológico , Simpatomiméticos/uso terapéutico , Contracción Uterina/efectos de los fármacos , Acidosis/etiología , Femenino , Enfermedades Fetales/etiología , Humanos , Recién Nacido , EmbarazoRESUMEN
The immunology of propagation and growth is a field of medicine which has been developing in the last 3--4 years. On the basis of the literature data on clinical and experimental works from this field the author tries to explain the essence of the immunological mother-fetus relationship. The non-rejection of the fetus as a foreign transplant is made possible by the suppression of the mother's immunologic capacity (cellular and humoral) on the one hand, and the existence of protective mechanisms of the fetus on the other. Dealing in more detail with elements resulting in the reduced immunological reactivity and the increased tolerance of mother towards fetus, the author concludes that this increased tolerance, along with the existence of the intact placental barrier, is the basic factor which allows the survival of the fetus as an allotransplant.